Rilotumumab: Difference between revisions

Jump to navigation Jump to search
m (Protected "Rilotumumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
Line 20: Line 20:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 26: Line 26:


{{humanmonoclonals}}
{{humanmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 15:45, 20 August 2012

Template:Drugbox-mab

WikiDoc Resources for Rilotumumab

Articles

Most recent articles on Rilotumumab

Most cited articles on Rilotumumab

Review articles on Rilotumumab

Articles on Rilotumumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Rilotumumab

Images of Rilotumumab

Photos of Rilotumumab

Podcasts & MP3s on Rilotumumab

Videos on Rilotumumab

Evidence Based Medicine

Cochrane Collaboration on Rilotumumab

Bandolier on Rilotumumab

TRIP on Rilotumumab

Clinical Trials

Ongoing Trials on Rilotumumab at Clinical Trials.gov

Trial results on Rilotumumab

Clinical Trials on Rilotumumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Rilotumumab

NICE Guidance on Rilotumumab

NHS PRODIGY Guidance

FDA on Rilotumumab

CDC on Rilotumumab

Books

Books on Rilotumumab

News

Rilotumumab in the news

Be alerted to news on Rilotumumab

News trends on Rilotumumab

Commentary

Blogs on Rilotumumab

Definitions

Definitions of Rilotumumab

Patient Resources / Community

Patient resources on Rilotumumab

Discussion groups on Rilotumumab

Patient Handouts on Rilotumumab

Directions to Hospitals Treating Rilotumumab

Risk calculators and risk factors for Rilotumumab

Healthcare Provider Resources

Symptoms of Rilotumumab

Causes & Risk Factors for Rilotumumab

Diagnostic studies for Rilotumumab

Treatment of Rilotumumab

Continuing Medical Education (CME)

CME Programs on Rilotumumab

International

Rilotumumab en Espanol

Rilotumumab en Francais

Business

Rilotumumab in the Marketplace

Patents on Rilotumumab

Experimental / Informatics

List of terms related to Rilotumumab


Overview

Rilotumumab is a human monoclonal antibody and which it is used to treat cancer.

Template:Humanmonoclonals Template:WH Template:WS